NewsRoom Articles - Page 125 of 133 - PsychedelicNewsWire (PNW)

WednesdayJul 18, 2018 9:00 am

Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines

PsychedelicNewsWire Editorial Coverage: The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option. An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a number of different products such as topicals, tinctures, and capsules. The World Health Organization (WHO) has found CBD to be nonpsychoactive, nonaddictive, and to have a positive effect on patients’ health. Scientific studies have shown CBD to be effective in pain relief and, therefore, it may be a healthier alternative to addictive opioids. Marijuana Company of…

FridayJun 29, 2018 12:52 pm

Marijuana Company of America, Inc. (MCOA) Launches CBD Infused Facial Moisturizer through hempSMART™ Subsidiary

MCOA focusing on non-psychoactive hemp cultivation and product markets Hemp industry’s predicted five-year CAGR of 25 percent expected to take it to $2.6 billion by 2022 hempSMART Face marks subsidiary’s extension into cosmetic products arena Progressive trends in the adoption of hemp-derived products continue to boost the prospects of Marijuana Company of America, Inc. (OTC: MCOA) and its hempSMART™ brand, which announced on June 19 the rollout of its latest cannabidiol-derived cosmetic product for people seeking an all-natural botanical moisturizer. The hempSMART™ Face product marks Marijuana Company of America’s expansion of its hempSMART™ brand into the cosmetic products space, building…

WednesdayJun 27, 2018 9:00 am

Farm Bill Legislation May Springboard Federal Hemp Acceptance

PsychedelicNewsWire Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a…

FridayJun 22, 2018 12:54 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Notes Rising Interest in Economic Potential of Industrial Hemp

U.S. legislation to legalize industrial hemp makes significant headway in Congress Non-psychoactive cannabidiol (“CBD”) extracted from industrial hemp expected to become a $1 billion market by 2020 Industrial hemp increasingly seen as an economic boon for farmers seeking alternative agricultural revenue sources Cash Crop Today Investor and Business Resource Summit delivers successful launch during U.S. Hemp History Week Global Hemp Group Inc. (CSE: GHG) (OTC: GBHPF) (FRANKFURT: GHG) has a vision when it comes to industrial hemp – “One world, one plant.” This seemingly simple statement about an ancient plant with so many beneficial uses is ringing true to investors,…

FridayJun 15, 2018 12:22 pm

Marijuana Company of America, Inc. (MCOA) Relaunches Improved hempSMART™ Brain Formulation

Significant changes within politics paint a promising picture for the cannabinoid industry MCOA is involved in the cultivation, manufacture and distribution of hemp-derived products MCOA recently announced the launch of its reformulated, patent pending product, hempSMART™ Brain President Trump recently made the statement that he is likely to back the States Act introduced by Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA), which removes federal involvement into state-by-state medical and recreational cannabis legislation. This is great news for those in the U.S. cannabinoid market (http://cnw.fm/M4klw). Also, significant changes have taken place in the political acceptance of the cultivation of hemp on…

WednesdayJun 13, 2018 12:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focusing on Delivery of Bioactive Substances via Oral Ingestion

Lexaria has its patented DehydraTECH™ nutrient infusion technology This technology has patent protection for cannabidiol and all other non-psychoactive cannabinoids DehydraTECH™ technology provides greater bio-absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is a worldwide leader in enhancing the gastro-intestinal delivery of edible cannabinoid products. The company has its patented nutrient infusion technology called DehydraTECH™. This technology significantly improves the body’s ability to absorb cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, nicotine, drugs, supplements and other beneficial molecules. Lexaria Bioscience is headquartered in Kelowna, British Columbia. Lexaria has patents granted in the United States and Australia for applications of its…

WednesdayJun 13, 2018 11:28 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Extends Share Warrants Expiry amid Growing Alternative Medicine Popularity

PreveCeutical moves on recent stock split to boost share appeal Company’s organic therapeutics aim to relieve maladies for patients with diabetes, brain injuries and other conditions Alternative medicines market expected to generate nearly $200 billion in revenues by 2025 PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) continues working to shore up its share appeal while seeking remedies for a variety of physical ailments through its nature-centric research to help patients with type 2 diabetes and obesity, mild traumatic brain injury, cancer and pervasive pain. PreveCeutical Medical completed a forward stock split last month on the basis of five…

MondayJun 11, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of Dietary Supplement, Drug Delivery Markets

Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation PreveCeutical developing Sol-Gel, an innovative medicine delivery platform Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years. In a report published in May, Technavio estimated that the global dietary…

FridayJun 08, 2018 12:33 pm

Marijuana Company of America, Inc. (MCOA) Building a Vertically Integrated Hemp Company amid Growing Advocacy for Versatile Plant

Non-psychoactive hemp’s varied uses comprise $500 million-plus industry with billion-dollar reach JV binds partners in growing New Brunswick and Oregon hemp cultivation projects Support increasing for U.S. Congressional drive to legalize hemp Hemp advocates at Marijuana Company of America, Inc. (OTC: MCOA) are advancing cultivation projects that will give the company a significant supply of non-intoxicating cannabidiol (CBD) for market under the hempSMART and BeniHemp brands. The wholly owned hempSMART subsidiary strategically works to build share value through the distribution of CBD-based health and wellness products via a network marketing model, and BeniHemp offers hemp-derived CBD products to consumer retail…

ThursdayMay 31, 2018 9:00 am

CBD Market Set for Huge Growth

PsychedelicNewsWire Editorial Coverage: In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050